januari
world
health
organ
design
outbreak
novel
coronaviru
seen
human
public
health
emerg
intern
concern
pheic
follow
declar
pandem
march
sever
acut
respiratori
syndrom
coronaviru
previous
refer
viru
respons
caus
coronaviru
diseas
pandem
trace
earli
begin
report
cluster
unexplain
pneumonia
case
late
decemb
origin
seafood
live
anim
market
wuhan
hubei
provinc
china
outset
caus
agent
thought
viral
patient
report
fever
dyspnea
unpreced
number
individu
travel
restrict
quarantin
worldwid
spread
known
cure
vaccin
yet
avail
proven
formid
adversari
ebola
viru
diseas
evd
outbreak
west
africa
provid
valuabl
lesson
regard
emerg
prepared
person
protect
equip
use
triag
process
underscor
import
role
emerg
physician
play
frontlin
emerg
infecti
diseas
describ
virolog
epidemiolog
clinic
present
radiograph
laboratori
find
current
test
protocol
manag
patient
present
emerg
depart
ed
review
articl
provid
emerg
physician
best
practic
base
rapidli
evolv
bodi
literatur
surround
member
coronaviru
famili
name
crownlik
appear
spike
viru
surfac
member
coronaviru
famili
includ
middl
east
respiratori
syndrom
coronaviru
merscov
well
coronavirus
respons
common
cold
fig
like
merscov
betacoronaviru
like
associ
anim
reservoir
eg
bat
exact
anim
sourc
confirm
mani
earli
case
china
link
live
anim
seafood
market
american
journal
emerg
medicin
xxx
xxxx
xxx
major
initi
case
associ
travel
hubei
provinc
china
howev
grow
number
case
due
persontoperson
transmiss
report
outsid
china
fig
case
report
origin
hubei
provinc
decemb
march
greatest
number
new
case
report
itali
spain
germani
unit
state
us
fig
base
known
coronavirus
expert
believ
primarili
spread
persontoperson
close
contact
approxim
ft
respiratori
droplet
transmiss
viru
contamin
surfac
fomit
subsequ
contact
eye
nose
mouth
may
also
occur
patient
felt
highest
risk
spread
ill
symptomat
limit
data
support
viral
shed
asymptomat
patient
increas
level
viral
shed
may
pronounc
critic
ill
current
epidemiolog
pattern
china
indic
highli
contagi
sustain
spread
extent
persontoperson
transmiss
within
us
initi
limit
progress
commun
transmiss
mani
part
countri
current
r
basic
reproduct
number
estim
everi
case
identifi
popul
addit
case
possibl
absenc
adequ
isol
earli
epidemiolog
analysi
case
wuhan
china
median
patient
age
year
male
largest
studi
date
compris
patient
record
februari
china
patient
year
age
case
report
mild
overal
case
fatal
rate
pediatr
case
report
patient
age
year
repres
case
approxim
laboratori
confirm
case
occur
healthcar
personnel
case
either
sever
critic
classifi
sever
follow
characterist
requir
b
oxygen
satur
presenc
lung
infiltr
within
h
respir
breathsmin
dyspnea
critic
patient
defin
septic
shock
multipl
organ
dysfunctionfailur
andor
respiratori
failur
account
approxim
studi
popul
case
fatal
rate
highest
case
fatal
rate
observ
older
year
patient
without
comorbid
case
fatal
rate
contrast
comorbid
condit
cardiovascular
diseas
caution
exercis
interpret
earli
find
underreport
variabl
test
practic
concern
case
fatal
rate
hubei
provinc
report
confid
interv
ci
outsid
mainland
china
rang
mortal
rate
calcul
high
compar
recent
epidem
sar
evd
averag
case
fatal
rate
much
lower
tabl
comparison
influenza
pandem
influenza
season
respons
approxim
time
case
base
known
similar
coronavirus
longest
potenti
incub
period
thought
day
initi
exposur
mean
incub
period
day
ci
rang
day
coinfect
occur
patient
may
higher
critic
patient
risk
factor
sever
diseas
includ
advanc
age
chronic
medic
condit
immunocompromis
cancer
data
regard
pregnanc
limit
pregnant
women
fetus
may
vulner
infect
compar
gener
popul
case
report
pregnant
women
diagnos
complic
advers
outcom
includ
preterm
birth
histor
infant
born
mother
coronavirus
merscov
small
gestat
age
preterm
newborn
infant
also
atrisk
popul
occup
exposur
pathogen
inher
risk
work
healthcar
set
sar
outbreak
healthcar
profession
hcp
toronto
canada
particip
endotrach
intub
infect
patient
becam
infect
anoth
studi
sar
patient
toronto
tie
hospit
set
case
hcp
influenza
pandem
hcp
significantli
like
develop
infect
odd
ratio
ci
pool
preval
disproportion
affect
hcp
emerg
physician
must
vigil
potenti
exposur
risk
adher
appropri
infect
prevent
precaut
itali
anywher
hcp
infect
symptom
similar
viral
upper
respiratori
ill
includ
fever
cough
fatigu
dyspnea
differenti
diagnosi
tailor
patient
present
symptom
comorbid
influenza
respiratori
syncyti
viru
rsv
viral
ill
bacteri
pneumonia
consid
well
pulmonari
diseas
ie
pulmonari
embol
complet
thorough
yet
focus
histori
physic
examin
obtain
collater
histori
famili
member
vital
asid
pulmonari
symptom
patient
may
initi
present
vagu
complaint
includ
diarrhea
lethargi
myalgia
nausea
patient
may
also
experi
headach
confus
vomit
pleurisi
sore
throat
sneez
rhinorrhea
nasal
congest
case
seri
patient
median
age
year
wuhan
china
found
commonli
report
symptom
cough
fever
dyspnea
case
seri
patient
also
report
myalgiasfatigu
product
cough
headach
hemoptysi
diarrhea
nationwid
studi
case
across
china
common
present
symptom
includ
cough
fever
fatigu
sputum
product
short
breath
fever
predomin
symptom
time
initi
present
patient
sever
diseas
dyspnea
may
present
patient
progress
acut
lung
injuri
patient
one
studi
patient
confirm
suggest
patient
gastrointestin
gi
symptom
symptom
may
includ
anorexia
diarrhea
vomit
abdomin
pain
seven
patient
gi
symptom
respiratori
symptom
atyp
present
infect
gener
may
like
elderli
immunocompromis
may
mount
febril
respons
increas
sensit
identifi
potenti
patient
sooner
us
center
diseas
control
prevent
cdc
recommend
use
temperatur
cutoff
f
patient
older
year
age
comorbid
may
also
present
sever
diseas
compar
popul
three
major
trajectori
describ
mild
diseas
upper
respiratori
symptom
nonsever
pneumonia
sever
pneumonia
complic
acut
respiratori
distress
syndrom
ard
necessit
aggress
resuscit
measur
anywher
patient
may
develop
ard
complic
includ
secondari
bacteri
infect
acut
kidney
injuri
septic
shock
ventilatorassoci
pneumonia
cardiac
injuri
emerg
medicin
approach
focu
identifi
isol
patient
risk
infect
inform
hospit
infect
prevent
local
public
health
author
engag
infecti
diseas
specialist
earli
care
world
health
organ
establish
case
contact
definit
standard
global
surveil
tabl
patient
confirm
subject
confirm
fever
andor
symptom
acut
respiratori
ill
eg
cough
difficulti
breath
concert
clinician
judgment
regard
patient
present
compat
cdc
guidelin
priorit
patient
defin
popul
evalu
test
person
investig
pui
tabl
criteria
exhaust
patient
unestablish
etiolog
equivoc
histori
exposur
may
consid
test
individu
basi
confirm
local
case
set
known
commun
transmiss
reduc
threshold
evalu
ed
collabor
local
state
public
health
depart
strongli
recommend
pui
ask
wear
facemask
reduc
risk
transmiss
other
immedi
vicin
fig
detail
cdc
recommend
identifi
assess
suspect
emerg
medic
servic
em
director
public
health
author
work
conjunct
cdc
need
modifi
emerg
prepared
strategi
address
emerg
medic
dispatch
consid
whether
caller
describ
risk
factor
symptom
concern
contact
person
experienc
one
follow
exposur
day
day
onset
symptom
probabl
confirm
case
facetofac
contact
probabl
confirm
case
within
min
direct
physic
contact
probabl
confirm
case
direct
care
patient
probabl
confirm
diseas
without
use
proper
person
protect
equip
situat
indic
local
risk
assess
note
confirm
asymptomat
case
period
contact
measur
day
day
date
sampl
taken
led
confirm
identifi
potenti
pui
em
personnel
arriv
onscen
well
hcp
receiv
hospit
notifi
immedi
ensur
proper
person
protect
equip
ppe
use
confirm
appropri
isol
facil
avail
contact
made
patient
initi
triag
assess
done
least
ft
meter
away
minim
pui
don
facemask
addit
limit
number
em
personnel
patient
compart
provid
direct
patient
care
follow
standard
droplet
surgic
mask
contact
precaut
gown
glove
wear
eye
protect
face
shield
goggl
airborn
precaut
respir
employ
patient
critic
ill
andor
aerosolgener
procedur
anticip
transport
ideal
transport
vehicl
isol
compart
high
effici
particul
air
hepa
filtrat
use
patient
transfer
directli
treatment
room
arriv
receiv
healthcar
facil
patient
transport
em
document
complet
patient
compart
door
left
open
allow
proper
ventil
clean
vehicl
dispos
gown
glove
surgic
mask
face
shield
worn
routin
clean
follow
applic
hospitalgrad
disinfect
prefer
one
approv
us
environment
protect
agenc
epa
use
emerg
viral
pathogen
includ
patient
present
symptom
concern
ed
separ
patient
least
ft
ask
wear
facemask
ideal
stabl
pui
would
identifi
time
checkin
triag
place
privat
room
door
close
critic
ill
patient
requir
aerosolgener
procedur
place
airborn
infect
isol
room
aiir
also
known
neg
pressur
isol
room
hepa
filtrat
recircul
air
pui
identifi
appropri
health
depart
agenc
institut
personnel
notifi
expediti
manner
movement
patient
treatment
room
limit
essenti
hcp
involv
patient
care
room
pui
may
remov
facemask
howev
reason
ask
patient
wear
facemask
interact
hcp
eg
perform
physic
examin
room
toler
contain
respiratori
droplet
gener
cough
hcp
either
use
alcoholbas
hand
sanit
wash
hand
soap
water
contact
pui
train
appropri
use
ppe
per
hospit
guidelin
includ
techniqu
safe
doff
equip
protect
mucou
membran
care
stabl
pui
hcp
adher
droplet
surgic
mask
contact
gown
glove
standard
precaut
addit
eye
protect
face
shield
goggl
pui
critic
ill
aerosolgener
procedur
eg
endotrach
intub
suction
airway
sputum
induct
necessari
hcp
escal
airborn
precaut
use
fit
respir
place
surgic
mask
reusabl
respir
power
air
purifi
respir
papr
may
also
use
disinfect
maintain
appropri
patient
histori
exposur
present
noninfecti
symptom
may
evalu
treat
adher
standard
precaut
alon
portabl
studi
eg
plain
radiographi
complet
within
patient
room
patient
requir
transport
elsewher
within
ed
hospit
wheelchair
stretcher
hcp
appropri
ppe
healthcar
profession
destin
receiv
locat
made
awar
patient
arriv
likewis
appropri
ppe
patient
leav
treatment
room
wear
facemask
dress
clean
hospit
gown
possibl
perform
hand
hygien
educ
proper
respiratori
hygien
personnel
clean
empti
pui
room
follow
droplet
contact
standard
precaut
eye
protect
infecti
particl
may
present
unclear
long
remain
air
draw
parallel
airborn
diseas
tuberculosi
help
particularli
aerosolgener
procedur
perform
frequent
use
surfac
clean
least
twice
daili
implement
standard
institut
clean
procedur
intub
highrisk
procedur
due
aerosol
respiratori
droplet
rescu
intub
avoid
whenev
possibl
complet
adher
ppe
may
inadequ
timesensit
critic
scenario
societi
critic
care
medicin
sccm
surviv
sepsi
guidelin
recommend
perform
endotrach
intub
airborn
precaut
includ
use
fit
respir
placement
patient
aiir
base
prior
case
hcp
infect
use
respir
expert
recommend
use
papr
experienc
provid
intub
reduc
inadvert
contamin
touch
one
face
hair
full
face
shield
head
cover
recommend
papr
use
wrist
exposur
minim
use
longersleev
glove
vertic
tape
glove
gown
appli
tape
circumferenti
make
remov
ppe
difficult
ad
benefit
shoe
cover
avoid
lead
accident
selfcontamin
instead
imperm
shoe
appropri
decontamin
worn
avail
coveral
without
hood
may
use
process
train
safe
dof
establish
beforehand
hcp
may
less
experienc
use
ppe
ensembl
order
inform
decis
relat
infect
control
symptomat
individu
older
adult
individu
chronic
medic
condit
andor
immunocompromis
state
may
put
higher
risk
poor
outcom
eg
diabet
heart
diseas
receiv
immunosuppress
medic
chronic
lung
diseas
chronic
kidney
diseas
person
includ
healthcar
personnel
within
day
symptom
onset
close
contact
b
suspect
laboratoryconfirm
c
patient
histori
travel
affect
geograph
area
within
day
symptom
onset
note
healthcar
personnel
test
may
consid
exposur
person
suspect
without
laboratori
confirm
often
extens
close
contact
vulner
patient
healthcar
set
even
mild
sign
symptom
eg
sore
throat
evalu
among
potenti
expos
healthcar
personnel
hcp
may
consid
doubl
glove
posit
wast
transport
receptacl
close
limit
droplet
andor
contact
transmiss
secur
contamin
equip
dispos
reprocess
preoxygen
optim
nonaerosol
gener
strategi
includ
head
bed
elev
jaw
thrust
use
posit
end
expiratori
pressur
valv
fiberopt
laryngoscopi
avoid
unless
absolut
necessari
atom
anesthet
caus
viru
becom
aerosol
preoxygen
least
min
oxygen
perform
rapid
sequenc
intub
rsi
may
use
nasal
cannula
though
may
increas
risk
contamin
reduc
risk
surgic
mask
place
patient
devic
noninvas
posit
pressur
ventil
nippv
may
increas
risk
aerosol
recommend
preoxygen
high
effici
hydrophob
filter
use
facemask
rest
respiratori
circuit
video
laryngoscopi
prefer
direct
laryngoscopi
increas
distanc
intub
patient
close
system
util
suction
intub
complet
emerg
physician
immedi
place
laryngoscop
outer
glove
along
equip
use
intub
doubl
ziplock
plastic
bag
presenc
higheffici
particul
air
hepa
filter
verifi
expiratori
limb
mechan
ventil
prior
patient
use
cdc
develop
real
time
revers
transcript
polymeras
chain
reaction
rtpcr
assay
detect
upper
lower
respiratori
specimen
obtain
pui
nasopharyng
swab
specimen
collect
test
lower
respiratori
tract
specimen
sputum
obtain
patient
product
cough
otherwis
bronchoalveolar
lavag
tracheal
aspir
substitut
serum
sampl
necessari
data
avail
regard
sensit
specif
test
fals
neg
may
seen
asymptomat
individu
earli
cours
diseas
may
high
viral
burden
patient
test
neg
use
sampl
taken
symptomat
like
diseas
howev
sensit
rtpcr
report
rang
singl
neg
rtpcr
use
exclud
diagnosi
especi
patient
earli
stage
diseas
sever
symptom
patient
neg
rtpcr
continu
suspicion
isol
recheck
sever
day
later
molecular
test
eg
respiratori
viru
panel
altern
diagnos
influenza
consid
pui
howev
coinfect
virus
may
occur
anemia
lymphopenia
hypoxemia
abnorm
kidney
liver
function
elev
creatin
kinas
ddimer
thrombocytopenia
increas
lactat
dehydrogenas
present
lymphocytopenia
occur
patient
interestingli
one
studi
found
procalcitonin
elev
patient
inflammatori
marker
like
serum
ferritin
creactiv
protein
elev
troponin
brain
natriuret
peptid
may
elev
cardiac
involv
obtain
patient
suspect
myocardi
infarct
heart
failur
advanc
imag
comput
tomographi
ct
requir
diagnosi
may
creat
addit
infect
prevent
challeng
ed
howev
obtain
ct
may
demonstr
sever
find
lung
find
may
present
imag
patient
develop
clinic
manifest
case
seri
patient
wuhan
china
admit
chest
ct
find
consist
pneumonia
patient
may
also
radiograph
groundglass
opac
anoth
studi
patient
found
patient
bilater
pneumonia
unilater
pneumonia
mottl
groundglass
opac
chest
xray
ct
imag
ultrasound
util
well
repeat
reliabl
radiat
inexpens
ultrasound
find
depend
stage
sever
diseas
detect
lesion
deeper
lung
patient
typic
demonstr
irregularthicken
pleural
line
scatteredconflu
b
line
consolid
variou
size
nontranslobar
translobar
consolid
lung
ultrasound
pleural
effus
typic
small
local
present
abnorm
typic
found
multipl
lung
zone
current
specif
treatment
exist
recommend
patient
sever
vaccin
studi
includ
dnabas
vectorbas
protein
base
vaccin
support
care
mainstay
treatment
prefer
acetaminophen
pneumonia
present
imag
patient
critic
ill
antibiot
recommend
patient
present
respiratori
insuffici
set
potenti
infect
given
supplementari
oxygen
maintain
oxygen
satur
higher
patient
requir
oxygen
therapi
acut
hypoxem
respiratori
failur
requir
intub
endotrach
intub
perform
hypoxem
respiratori
failur
requir
intub
improv
convent
oxygen
therapi
high
flow
nasal
cannula
hfnc
recommend
noninvas
posit
pressur
ventil
nippv
hfnc
avail
urgent
need
intub
trial
nippv
ventil
recommend
frequent
reassess
though
nippv
increas
risk
aerosol
nippv
may
result
patient
improv
sccm
make
clear
recommend
helmet
nippv
compar
mask
nippv
recommend
avoid
nippv
due
risk
aerosol
util
safe
high
risk
patient
cohort
clinician
use
appropri
ppe
patient
declin
despit
use
hfnc
nippv
intub
intub
indic
airborn
precaut
use
patient
ventil
use
tidal
volum
mlkg
predict
bodi
weight
plateau
pressur
cm
h
avail
patient
sever
ard
may
benefit
prone
ventil
h
per
day
overresuscit
intraven
fluid
avoid
potenti
worsen
oxygen
even
suspect
caus
patient
symptom
recommend
administ
empir
antibiot
neuraminidas
inhibitor
within
h
identifi
sepsi
earli
recognit
septic
shock
critic
manag
sepsi
focus
intraven
fluid
resuscit
antibiot
conserv
resuscit
strategi
bufferedbalanc
crystalloid
recommend
shock
hypoton
crystalloid
avoid
vasopressor
preferenti
norepinephrin
indic
persist
shock
goal
map
mmhg
continu
shock
despit
norepinephrin
vasopressin
ad
rather
increas
norepinephrin
dose
cardiac
dysfunct
present
persist
hypoperfus
dobutamin
recommend
system
steroid
hydrocortison
mg
per
day
consid
vasopressorrefractori
shock
anoth
indic
steroid
chronic
obstruct
pulmonari
diseas
exacerb
without
delay
antibiot
administr
bacteri
blood
cultur
obtain
clinic
trial
investig
drug
antivir
underway
although
none
current
approv
us
food
drug
administr
fda
tabl
remdesivir
demonstr
activ
merscov
sarscov
vitro
anim
model
vitro
studi
found
remdesivir
chloroquin
inhibit
viral
infect
studi
requir
result
singl
studi
patient
found
chloroquin
superior
control
reduc
pneumonia
exacerb
improv
imag
find
virusneg
convers
shorten
cours
diseas
studi
evalu
lopinavirritonavir
found
improv
patient
surviv
differ
detect
viral
rna
hydroxychloroquin
azithromycin
also
studi
singl
prospect
observ
studi
patient
receiv
hydroxychloroquin
demonstr
higher
rate
viral
load
reductiondisappear
though
patient
center
outcom
assess
medic
studi
includ
tocilizumab
favipiravir
clear
data
support
harm
benefit
angiotensin
convert
enzym
inhibitor
ace
receptor
blocker
arb
unless
author
clinic
approv
trial
monitor
emerg
use
unregist
intervent
framework
meuri
unlicens
treatment
administ
continu
renal
replac
therapi
crrt
extracorpor
membran
oxygen
ecmo
immunoglobulin
util
manag
definit
shown
benefici
patient
sever
symptom
hypoxemia
requir
oxygen
supplement
high
risk
clinic
deterior
ie
pneumonia
radiograph
sever
comorbid
may
requir
admiss
manag
monitor
patient
mild
symptom
signific
comorbid
without
concern
deterior
clinic
condit
may
candid
discharg
selfquarantin
two
week
home
monitor
patient
must
abil
safe
isol
home
prevent
transmiss
other
care
monitor
social
distanc
vital
compon
reduc
spread
viru
compris
limit
event
mass
gather
even
small
group
meet
individu
remain
ft
meter
apart
individu
health
depart
involv
earli
care
patient
assist
decis
regard
disposit
surveil
test
especi
confirmatori
test
result
avail
emerg
physician
counsel
patient
return
worrisom
symptom
includ
new
worsen
pulmonari
complaint
fever
develop
clinic
pathway
among
emerg
physician
infecti
diseas
specialist
health
depart
critic
safe
evalu
pui
commun
novel
coronaviru
affect
unpreced
number
peopl
date
patient
typic
present
combin
fever
cough
histori
exposur
either
close
contact
travel
affect
geograph
area
patient
mild
diseas
may
develop
sever
complic
includ
ard
multiorgan
failur
succumb
diseas
special
consider
given
extrem
age
immunocompromis
pregnant
women
cur
treatment
current
approv
emerg
physician
obtain
detail
travel
histori
patient
suspect
patient
present
symptom
acut
upper
respiratori
ill
fever
earli
recognit
isol
patient
ed
may
help
decreas
exposur
patient
healthcar
personnel
futur
research
necessari
expand
collect
knowledg
optim
patient
outcom
none
author
contribut
sc
sl
ak
bl
conceiv
idea
manuscript
contribut
substanti
write
edit
review
none
